Insider Trading activities of Deciphera Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Deciphera Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Deciphera Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Deciphera Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is DCPH. The reporting company's CIK number is 1654151.
The total value of stock buying since 2005 is $12,750,000.
The total value of stock sales since 2005 is $133,700.
The total value of stock option exercises since 2005 is $10,017.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Deciphera Pharmaceuticals, Inc. (DCPH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-01 0 $0 5,300 $133,700 5,300 $10,017
2017-10 750,000 $12,750,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Deciphera Pharmaceuticals, Inc. insiders (DCPH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-01-11 Flynn Daniel Lee (Chief Scientific Officer) Sale 300 26.00 7,800
2019-01-11 Flynn Daniel Lee (Chief Scientific Officer) Option Ex 300 1.89 567
2019-01-07 Kelly Thomas Patrick (Chief Financial Officer) Sale 5,000 25.18 125,900
2019-01-07 Kelly Thomas Patrick (Chief Financial Officer) Option Ex 5,000 1.89 9,450
2017-10-02 New Leaf Bpo Associates I, L.p. (10% Owner) Buy 375,000 17.00 6,375,000
2017-10-02 Ratcliffe Liam (Director) Buy 375,000 17.00 6,375,000

Insider trading activities including stock purchases, stock sales, and option exercises of DCPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Deciphera Pharmaceuticals, Inc. (symbol DCPH, CIK number 1654151) see the Securities and Exchange Commission (SEC) website.